ww in the news

WW International was downgraded to sell after missing earnings estimates, with its stock falling to $32.48 amid ongoing weight management service offerings.

WW International missed Q3 earnings but is focusing on integrating clinical care with behavioral programs, modernizing digital platforms, expanding partnerships, and launching new offerings to drive growth in weight management.

WeightWatchers beat Q3 revenue estimates despite a 10.8% sales decline and raised full-year guidance, but long-term revenue trends remain negative.

WeightWatchers beat Q3 revenue estimates despite a 10.8% sales decline and raised full-year guidance, but profitability and long-term revenue trends remain weak.

WW's Q3 2025 revenue fell 11% due to behavioral declines but clinical growth and strategic digital and medical integrations position it for future growth.

W.W. Grainger maintains strong profitability with an 11% net margin and steady cash flow, but faces slowing earnings growth and a premium valuation reflecting cautious future outlooks.

W.W. Grainger beat Q3 2025 earnings and revenue expectations, is exiting the UK market to focus on North America and Japan, and manages inflation and tariffs with pricing and tech investments.

WW will announce its Q3 2025 earnings on November 6 with a live webcast conference call at 8:30 a.m. ET.

Angela from The Velvet Peacock discusses new updates and an upcoming event involving the venue and Elysian Vitality Spa.

WW International's stock rose nearly 6% after partnering with Amazon to deliver obesity medications, while Darden Restaurants also saw gains following a positive analyst upgrade.

WW International's stock surged 12.5% following a partnership with Amazon Pharmacy to enhance access to weight management medications for its members.

WW International has received new analyst coverage highlighting its potential amid economic challenges and market uncertainty.

WeightWatchers beat Q2 revenue and earnings estimates but gave weak full-year guidance, leading to a significant stock drop amid mixed results in the specialized consumer services sector.

WeightWatchers beat Q2 revenue and earnings estimates but gave weak full-year guidance, causing a significant stock drop.

WeightWatchers beat Q2 revenue and earnings estimates but gave weak full-year guidance, leading to a significant stock drop amid mixed sector performance.

CJS Securities starts coverage on WW International Inc. with a Market Perform rating.

WW International introduced a menopause-focused weight loss program with Queen Latifah as spokesperson, combining medical care, nutrition, and community support.

WeightWatchers beat Q2 revenue estimates despite a 6.4% sales decline and improved operating margin, but membership and long-term revenue trends remain weak.

WW International sold shares, cut debt significantly, was relisted on NASDAQ, grew clinical revenue despite subscriber losses, and appointed a new Chief Experience Officer.

Weight Watchers completed debt restructuring and is focusing on integrating clinical care with behavioral programs, enhancing member experience, and expanding into women's health despite short-term challenges from medication transitions.